242
Views
17
CrossRef citations to date
0
Altmetric
Review Article

Technologies for localization and diagnosis of prostate cancer

, &
Pages 585-603 | Published online: 15 Dec 2009

References

  • Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., Boyle, P., 2007, Estimates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology, 18, 581–592.
  • Fitzsimons, N.J., Sun, L., Moul, J.W., 2007, Medical technologies for the diagnosis of prostate cancer. Expert Review of Medical Devices, 4, 227–239.
  • Sim, H.G., Cheng, C.W.S., 2005, Changing demography of prostate cancer in Asia. European Journal of Cancer, 41, 834–845.
  • Olsson, C., 1993, Prostatic cancer. Kidney International, 43, 955–965.
  • Hricak, H., Choyke, P.L., Eberhardt, S.C., Leibel, S.A., Scardino, P.T., 2007, Imaging prostate cancer: A multidisciplinary perspective. Radiology, 243, 28–53.
  • Kundra, V., 2006, Prostate cancer imaging. Seminars in Roentgenology, 41, 139–149.
  • Loch, T., 2007, Urologic imaging for localized prostate cancer in 2007. World Journal of Urology, 25, 121–129.
  • Fuchsjäger, M., Shukla-Dave, A., Akin, O., Barentsz, J., Hricak, H., 2008, Prostate cancer imaging. Acta Radiology, 49, 107–120.
  • Kim, C.K., Park, B.K., 2008, Update of prostate magnetic resonance imaging at 3T. Journal of Computer Assisted Tomography, 32, 163–172.
  • Kurhanewicz, J., Vigneron, D., Carroll, P., Coakley, F., 2008, Multiparametric magnetic resonance imaging in prostate cancer: present and future. Current Opinions in Urology, 18, 71–77.
  • Pallwein, L., Mitterberger, M., Pelzer, A., Bartsch, G., Strasser, H., Pinggera, G.M., Aigner, F., Gradl, J., Nedden, D.Z., Frauscher, F., 2008, Ultrasound of prostate cancer: recent advances. European Radiology, 18, 707–715.
  • Costello, L.C., Franklin, R.B., 2009, Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem. Prostate Cancer and Prostatic Diseases, 12, 17–24.
  • De Angelis, G., Rittenhouse, H.G., Mikolajczyk, S.D., Blair Shamel, L., Semjonow, A., 2007, Twenty years of PSA: from prostate antigen to tumor marker. Reviews in Urology, 9, 113–123.
  • McNeal, J.E., Redwine, E.A., Freiha, F.S., Stamey, T.A., 1988, Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. American Journal of Surgical Pathology, 12, 897–906.
  • Boczko, J., Messing, E., Dogra, V., 2006, Transrectal sonography in prostate evaluation. Radiologic Clinics of North America, 44, 679–687.
  • Gjengstø, P., Halvorsen, O.J., Akslen, L.A., Frugård, J., Hoisaeter, P.A., 2003, Benign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 patients. Urology, 62, 447–450.
  • Tang, J., Yang, J.C., Zhang, Y., Liu, X., Zhang, L., Wang, Z., Li, J., Luo, Y., Xu, J., Shi, H., 2007, Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study. BJU International, 100, 1091–1096.
  • Halpern, E.J., 2006, Contrast-enhanced ultrasound imaging of prostate cancer. Reviews in Urology, 8 Suppl 1, S29–S37.
  • Neal, D.E., Leung, H.Y., Powell, P.H., Hamdy, F.C., Donovan, J.L., 2000, Unanswered questions in screening for prostate cancer. European Journal of Cancer, 36, 1316–1321.
  • Zhu, Y., Williams, S., Zwiggelaar, R., 2006, Computer technology in detection and staging of prostate carcinoma: a review. Medical Image Analysis, 10, 178–199.
  • Bergh, A., Grönberg, H., Hedestig, O., Stattin, P., Widmark, A., Wikström, P., 2005, Prostatacancer—Mannens Gissel. (Umeå: Faculty of Medicine at Umeå University).
  • Raja, J., Ramachandran, N., Munneke, G., Patel, U., 2006, Current status of transrectal ultrasound guided prostate biopsy in the diagnosis of prostate cancer. Clinical Radiology, 61, 142–153.
  • Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B., Lindahl, O.A., 2006, Resonance sensor measurements of stiffness variations in prostate tissue in vitro—a weighted tissue proportion model. Physiological Measurement, 27, 1373–1386.
  • Miyanaga, N., Akaza, H., Yamakawa, M., Oikawa, T., Sekido, N., Hinotsu, S., Kawai, K., Shimazui, T., Shiina, T., 2006, Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report. International Journal of Urology, 13, 1514–1518.
  • Zhang, M., Nigwekar, P., Castaneda, B., Hoyt, K., Joseph, J.V., di Sant'Agnese, A., Messing, E.M., Strang, J.G., Rubens, D.J., Parker, K.J., 2008, Quantitative characterization of viscoelastic properties of human prostate correlated with histology. Ultrasound in Medicine and Biology, 34, 1033–1042.
  • Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Matveev, V.B., Schmid, H.P., Zattoni, F., 2008, EAU guidelines on prostate cancer. European Urology, 53, 68–80.
  • Hodge, K.K., McNeal, J.E., Terris, M.K., Stamey, T.A., 1989, Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. Journal of Urology, 142, 71–74; discussion 74–75.
  • Rabbani, F., Stroumbakis, N., Kava, B.R., Cookson, M.S., Fair, W.R., 1998, Incidence and clinical significance of false-negative sextant prostate biopsies. Journal of Urology, 159, 1247–1250.
  • Jones, J.S., Patel, A., Schoenfield, L., Rabets, J.C., Zippe, C.D., Magi-Galluzzi, C., 2006, Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. Journal of Urology, 175, 485–488.
  • Lane, B.R., Zippe, C.D., Abouassaly, R., Schoenfield, L., Magi-Galluzzi, C., Jones, J.S., 2008, Saturation technique does not decrease cancer detection during follow up after initial prostate biopsy. Journal of Urology, 79, 1746–1750.
  • Kirkham, A.P.S., Emberton, M., Allen, C., 2006, How good is MRI at detecting and characterising cancer within the prostate? European Urology, 50, 1163–1174; discussion 1175.
  • Catalona, W.J., Loeb, S., Han, M., 2006, Viewpoint: expanding prostate cancer screening. Annals of Internal Medicine, 144, 441–443.
  • Helzlsouer, K.J., Newby, J., Comstock, G.W., 2008, Prostate-specific antigen levels and subsequent prostate cancer: potential for screening. American Journal Of Epidemiology, 168, 841–844 (reprinted from Cancer Epidemiology, Biomarkers & Prevention, 1992, 1, 537–540).
  • USPSTF, 2008, Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 149, 185–191.
  • Ahyai, S.A., Graefen, M., Steuber, T., Haese, A., Schlomm, T., Walz, J., Köllermann, J., Briganti, A., Zacharias, M., Friedrich, M.G., Karakiewicz, P.I., Montorsi, F., Huland, H., Chun, F.K.-H., 2008, Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter. European Urology, 53, 750–757.
  • Thompson, I.M., Pauler, D.K., Goodman, P.J., Tangen, C.M., Lucia, M.S., Parnes, H.L., Minasian, L.M., Ford, L.G., Lippman, S.M., Crawford, E.D., Crowley, J.J., Coltman, C.A., 2004, Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. New England Journal of Medicine, 350, 2239–2246.
  • Montironi, R., Mazzuccheli, R., Scarpelli, M., Lopez-Beltran, A., Fellegara, G., Algaba, F., 2005, Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies. BJU International, 95, 1146–1152.
  • Coard, K.C., Freeman, V.L., 2004, Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies. American Journal of Clinical Pathology, 122, 373–376.
  • Fukagai, T., Namiki, T., Namiki, H., Carlile, R.G., Shimada, M., Yoshida, H., 2001, Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. Pathology International, 51, 364–370.
  • Maygarden, S.J., Pruthi, R., 2005, Gleason grading and volume estimation in prostate needle biopsy specimens: evolving issues. American Journal of Clinical Pathology, 123 Suppl, S58–S66.
  • Ooi, K., Samali, R., 2007, Discrepancies in Gleason scoring of prostate biopsies and radical prostatectomy specimens and the effects of multiple needle biopsies on scoring accuracy.A regional experience in Tamworth, Australia. ANZ Journal of Surgery, 77, 336–338.
  • Tomioka, S., Nakatsu, H., Suzuki, N., Murakami, S., Matsuzaki, O., Shimazaki, J., 2006, Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer. International Journal of Urology, 13, 555–559.
  • Aihara, M., Wheeler, T.M., Ohori, M., Scardino, P.T., 1994, Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology, 43, 60–66; discussion 66–67.
  • Sooriakumaran, P., Lovell, D.P., Henderson, A., Denham, P., Langley, S.E.M., Laing, R.W., 2005, Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer. Clinical Oncology, 17, 655–658.
  • Dall'Era, M.A., Konety, B.R., Cowan, J.E., Shinohara, K., Stauf, F., Cooperberg, M.R., Meng, M.V., Kane, C.J., Perez, N., Master, V.A., Carroll, P.R., 2008, Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer, 112, 2664–2670.
  • Yin, M., Bastacky, S., Chandran, U., Becich, M.J., Dhir, R., 2008, Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. Journal of Urology, 179, 892–895; discussion 895.
  • Watanabe, H., Kaiho, H., Tanaka, M., Terasawa, Y., 1971, Diagnostic application of ultrasonotomography to the prostate. Investigative Urology, 8, 548–559.
  • Watanabe, H., Igari, D., Tanahashi, Y., Harada, K., Saito, M., 1974, Measurements of size and weight of prostate by means of transrectal ultrasonotomography. Tohoku Journal of Experimental Medicine, 114, 277–285.
  • Watanabe, H., Igari, D., Tanahashi, Y., Harada, K., Saitoh, M., 1975, Transrectal ultrasonotomography of the prostate. Journal of Urology, 114, 734–739.
  • Watanabe, H., Igari, D., Tanahashi, Y., Harada, K., Saitoh, M., 1976, An evaluation of the function of new special equipment for transrectal ultrasonotomography. Tohoku Journal of Experimental Medicine, 118, 387–392.
  • Toi, A., Neill, M.G., Lockwood, G.A., Sweet, J.M., Tammsalu, L.A., Fleshner, N.E., 2007, The continuing importance of transrectal ultrasound identification of prostatic lesions. Journal of Urology, 177, 516–520.
  • Oyen, R.H., Van de Voorde, W.M., Van Poppel, H.P., Brys, P.P., Ameye, F.E., Franssens, Y.M., Baert, A.L., Baert, L.V., 1993, Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland. Radiology, 189, 707–711.
  • Lee, F., Torp-Pedersen, S., Littrup, P.J., McLeary, R.D., McHugh, T.A., Smid, A.P., Stella, P.J., Borlaza, G.S., 1989, Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology, 170, 29–32.
  • Carter, H.B., Hamper, U.M., Sheth, S., Sanders, R.C., Epstein, J.I., Walsh, P.C., 1989, Evaluation of transrectal ultrasound in the early detection of prostate cancer. Journal of Urology, 142, 1008–1010.
  • Flanigan, R.C., Catalona, W.J., Richie, J.P., Ahmann, F.R., Hudson, M.A., Scardino, P.T., deKernion, J.B., Ratliff, T.L., Kavoussi, L.R., Dalkin, B.L., 1994, Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. Journal of Urology, 152, 1506–1509.
  • Carey, B.M., 2005, Imaging for prostate cancer. Clinical Oncology, 17, 553–559.
  • Mohamed, S.S., Salama, M.M.A., Kamel, M., El-Saadany, E.F., Rizkalla, K., Chin, J., 2005, Prostate cancer multi-feature analysis using trans-rectal ultrasound images. Physics in Medicine and Biology, 50, N175–N185.
  • Padhani, A.R., Harvey, C.J., Cosgrove, D.O., 2005, Angiogenesis imaging in the management of prostate cancer. Nature Clinical Practice Urology, 2, 596–607.
  • Bude, R.O., Rubin, J.M., 1996, Power Doppler sonography. Radiology, 200, 21–23.
  • Rubin, J.M., Bude, R.O., Carson, P.L., Bree, R.L., Adler, R.S., 1994, Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology, 190, 853–856.
  • Amiel, G.E., Slawin, K.M., 2006, Newer modalities of ultrasound imaging and treatment of the prostate. Urologic Clinics of North America, 33, 329–337.
  • Arger, P.H., Malkowicz, S.B., Van Arsdalen, K.N., Sehgal, C.M., Holzer, A., Schultz, S.M., 2004, Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity. Journal of Ultrasound Medicine, 23, 623–630.
  • Halpern, E.J., Strup, S.E., 2000, Using gray-scale and color and power Doppler sonography to detect prostatic cancer. American Journal of Roentgenology, 174, 623–627.
  • Sauvain, J.L., Palascak, P., Bourscheid, D., Chabi, C., Atassi, A., Bremon, J.M., Palascak, R., 2003, Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. European Urology, 44, 21–30; discussion 30–1.
  • Sauvain, J.L., Palascak, P., Nader, N., Gomez, W., Bloqueau, Ph., Bremon, J.M., Jung, L., Maniere, Ph., Papavero, R., 2006, Power Doppler Imaging and prostate cancer: optional or necessary technique? Journal of Radiology, 87, 1063–1072.
  • Berger, A.P., Horninger, W., Bektic, J., Pelzer, A., Spranger, R., Bartsch, G., Frauscher, F., 2006, Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU International, 98, 587–590.
  • Kojima, M., Ochiai, A., Naya, Y., Okihara, K., Ukimura, O., Miki, T., 2000, Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. European Urology, 37, 436–442.
  • Turgut, A.T., Olücüoglu, E., Kosar, P., Geyik, P.O., Kosar, U., Dogra, V., 2007, Power Doppler ultrasonography of the feeding arteries of the prostate gland: a novel approach to the diagnosis of prostate cancer? Journal of Ultrasound Medicine, 26, 875–883.
  • Frauscher, F., Klauser, A., Halpern, E.J., Horninger, W., Bartsch, G., 2001, Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet, 357, 1849–1850.
  • Frauscher, F., Klauser, A., Volgger, H., Halpern, E.J., Pallwein, L., Steiner, H., Schuster, A., Horninger, W., Rogatsch, H., Bartsch, G., 2002, Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. Journal of Urology, 167, 1648–1652.
  • Mitterberger, M., Pinggera, G.M., Horninger, W., Bartsch, G., Strasser, H., Schäfer, G., Brunner, A., Halpern, E.J., Gradl, J., Pallwein, L., Frauscher, F., 2007, Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. Journal of Urology, 178, 464–468; discussion 468.
  • Mitterberger, M., Horninger, W., Pelzer, A., Strasser, H., Bartsch, G., Moser, P., Halpern, E.J., Gradl, J., Aigner, F., Pallwein, L., Frauscher, F., 2007, A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection. Prostate, 67, 1537–1542.
  • Mitterberger, M., Pinggera, G., Horninger, W., Strasser, H., Halpern, E., Pallwein, L., Gradl, J., Bartsch, G., Frauscher, F., 2008, Dutasteride prior to contrast-enhanced colour Doppler ultrasound prostate biopsy increases prostate cancer detection. European Urology, 53, 112–117.
  • Halpern, E.J., Frauscher, F., Rosenberg, M., Gomella, L.G., 2002, Directed biopsy during contrast-enhanced sonography of the prostate. American Journal of Roentgenology, 178, 915–919.
  • Halpern, E.J., Ramey, J.R., Strup, S.E., Frauscher, F., McCue, P., Gomella, L.G., 2005, Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer, 104, 2373–2383.
  • Halpern, E.J., McCue, P.A., Aksnes, A.K., Hagen, E.K., Frauscher, F., Gomella, L.G., 2002, Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology, 222, 361–366.
  • Wink, M., Frauscher, F., Cosgrove, D., Chapelon, J.-Y., Palwein, L., Mitterberger, M., Harvey, C., Rouviere, O., de la Rosette, J., Wijkstra, H., 2008, Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. European Urology, 54, 982–993.
  • Phillips, P., Gardner, E., 2004, Contrast-agent detection and quantification. European Radiology, 14 Suppl 8, P4–10.
  • Yang, J.C., Tang, J., Li, J., Luo, Y., Li, Y., Shi, H., 2008, Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels. Academic Radiology, 15, 1291–1297.
  • Mehta, S.S., Azzouzi, A.R., Hamdy, F.C., 2004, Three dimensional ultrasound and prostate cancer. World Journal of Urology, 22, 339–345.
  • Sedelaar, J.P., van Roermund, J.G., van Leenders, G.L., Hulsbergen-van de Kaa, C.A., Wijkstra, H., de la Rosette, J.J., 2001, Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology, 57, 914–920.
  • Bogers, H.A., Sedelaar, J.P., Beerlage, H.P., de la Rosette, J.J., Debruyne, F.M., Wijkstra, H., Aarnink, R.G., 1999, Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology, 54, 97–104.
  • Sedelaar, J.P.M., van Leenders, G.J.L.H., Goossen, T.E.B., Hulsbergen-van der Kaa, C.A., van Adrichem, N.P., Wijkstra, H., de la Rosette, J.J.M.C.H., 2002, Value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. Prostate, 53, 246–253.
  • Ophir, J., Cspedes, I., Ponnekanti, H., Yazdi, Y., Li, X., 1991, Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrasonic Imaging, 13, 111–134.
  • König, K., Scheipers, U., Pesavento, A., Lorenz, A., Ermert, H., Senge, T., 2005, Initial experiences with real-time elastography guided biopsies of the prostate. Journal of Urology, 174, 115–117.
  • Pallwein, L., Mitterberger, M., Struve, P., Pinggera, G., Horninger, W., Bartsch, G., Aigner, F., Lorenz, A., Pedross, F., Frauscher, F., 2007, Real-time elastography for detecting prostate cancer: preliminary experience. BJU International, 100, 42–46.
  • Pallwein, L., Mitterberger, M., Struve, P., Horninger, W., Aigner, F., Bartsch, G., Gradl, J., Schurich, M., Pedross, F., Frauscher, F., 2007, Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. European Radiology, 17, 2278–2285.
  • Pallwein, L., Mitterberger, M., Pinggera, G., Aigner, F., Pedross, F., Gradl, J., Pelzer, A., Bartsch, G., Frauscher, F., 2008, Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. European Journal of Radiology, 65, 304–310.
  • Tsutsumi, M., Miyagawa, T., Matsumura, T., Kawazoe, N., Ishikawa, S., Shimokama, T., Shiina, T., Miyanaga, N., Akaza, H., 2007, The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis. International Journal of Clinical Oncology, 12, 250–255.
  • Sumura, M., Shigeno, K., Hyuga, T., Yoneda, T., Shiina, H., Igawa, M., 2007, Initial evaluation of prostate cancer with real-time elastography based on step-section pathologic analysis after radical prostatectomy: a preliminary study. International Journal of Urology, 14, 811–816.
  • Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B., Lindahl, O.A., 2008, Explanatory models for a tactile resonance sensor system-elastic and density-related variations of prostate tissue in vitro. Physiological Measurement, 29, 729–745.
  • Omata, S., Terunuma, Y., 1992, New tactile sensor like the human hand and its applications. Sensors and Actuators A, 35, 9–15.
  • Eklund, A., Bergh, A., Lindahl, O.A., 1999, A catheter tactile sensor for measuring hardness of soft tissue: measurement in a silicone model and in an in vitro human prostate model. Medical & Biological Engineering & Computing, 37, 618–624.
  • Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B., Lindahl, O.A., 2006, Prostate tissue stiffness as measured with a resonance sensor system: a study on silicone and human prostate tissue in vitro. Medical & Biological Engineering & Computing, 44, 593–603.
  • Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B., Lindahl, O.A., 2007, Spatial variations in prostate tissue histology as measured by a tactile resonance sensor. Physiological Measurement, 28, 1267–1281.
  • Lindberg, P., Andersson, B., Bergh, A., Ljungberg, B., Lindahl, O.A., 2006, Prostate cancer detection with an improved resonance sensor system: parameter evaluation in a silicone model and on human prostate tissue in vitro. Medical & Biological Engineering & Computing, 44, 1053–1059.
  • Smith, R.C., McCarthy, S., 1992, Physics of magnetic resonance. Journal of Reproductive Medicine, 37, 19–26.
  • Jordan, K.W., Cheng, L.L., 2007, NMR-based metabolomics approach to target biomarkers for human prostate cancer. Expert Reviews in Proteomics, 4, 389–400.
  • Trabulsi, E.J., Merriam, W.G., Gomella, L.G., 2006, New imaging techniques in prostate cancer. Current Urology Reports, 7, 175–180.
  • Oehr, P., Bouchelouche, K., 2007, Imaging of prostate cancer. Current Opinions in Oncology, 19, 259–264.
  • Wefer, A.E., Hricak, H., Vigneron, D.B., Coakley, F.V., Lu, Y., Wefer, J., Mueller-Lisse, U., Carroll, P.R., Kurhanewicz, J., 2000, Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. Journal of Urology, 164, 400–404.
  • Mullerad, M., Hricak, H., Kuroiwa, K., Pucar, D., Chen, H.-N., Kattan, M.W., Scardino, P.T., 2005, Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. Journal of Urology, 174, 2158–2163.
  • Akin, O., Sala, E., Moskowitz, C.S., Kuroiwa, K., Ishill, N.M., Pucar, D., Scardino, P.T., Hricak, H., 2006, Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology, 239, 784–792.
  • Casciani, E., Gualdi, G., 2006, Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging. Abdominal Imaging, 31, 490–499.
  • Rajesh, A., Coakley, F.V., 2004, MR imaging and MR spectroscopic imaging of prostate cancer. Magnetic Resonance Imaging Clinics of North America, 12, 557–579.
  • Kurhanewicz, J., Vigneron, D.B., Hricak, H., Narayan, P., Carroll, P., Nelson, S.J., 1996, Three dimensional H-1MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm3) spatial resolution. Radiology, 198, 795–805.
  • Jung, J.A., Coakley, F.V., Vigneron, D.B., Swanson, M.G., Qayyum, A., Weinberg, V., Jones, K.D., Carroll, P.R., Kurhanewicz, J., 2004, Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology, 233, 701–708.
  • Fütterer, J.J., Scheenen, T.W.J., Heijmink, S.W.T.P.J., Huisman, H.J., de Kaa, C., Witjes, J.A., Heerschap, A., Barentsz, J.O., 2007, Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Investigative Radiology, 42, 116–122.
  • Wang, P., Guo, Y., Liu, M., Qiang, Y., Guo, X., Zhang, Y., Duan, X.-Y., Zhang, Q.-J., Liang, W., 2008, A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool. Korean Journal of Radiology, 9, 432–438.
  • Vilanova, J.C., Barcel, J., 2007, Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging. Abdominal Imaging, 32, 253–261.
  • Scheidler, J., Hricak, H., Vigneron, D.B., Yu, K.K., Sokolov, D.L., Huang, L.R., Zaloudek, C.J., Nelson, S.J., Carroll, P.R., Kurhanewicz, J., 1999, Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging–clinicopathologic study. Radiology, 213, 473–480.
  • Yu, K.K., Scheidler, J., Hricak, H., Vigneron, D.B., Zaloudek, C.J., Males, R.G., Nelson, S.J., Carroll, P.R., Kurhanewicz, J., 1999, Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology, 213, 481–488.
  • Kurhanewicz, J., Vigneron, D.B., Nelson, S.J., 2000, Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia, 2, 166–189.
  • Zakian, K.L., Sircar, K., Hricak, H., Chen, H.-N., Shukla-Dave, A., Eberhardt, S., Muruganandham, M., Ebora, L., Kattan, M.W., Reuter, V.E., Scardino, P.T., Koutcher, J.A., 2005, Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology, 234, 804–814.
  • Wang, L., Hricak, H., Kattan, M.W., Chen, H.-N., Scardino, P.T., Kuroiwa, K., 2006, Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology, 238, 597–603.
  • Shukla-Dave, A., Hricak, H., Kattan, M.W., Pucar, D., Kuroiwa, K., Chen, H.-N., Spector, J., Koutcher, J.A., Zakian, K.L., Scardino, P.T., 2007, The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU International, 99, 786–793.
  • Kumar, R., Nayyar, R., Kumar, V., Gupta, N.P., Hemal, A.K., Jagannathan, N.R., Dattagupta, S., Thulkar, S., 2008, Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study. Urology, 72, 859–863.
  • Fütterer, J.J., Heijmink, S.W.T.P.J., Scheenen, T.W.J., Veltman, J., Huisman, H.J., Vos, P., Hulsbergen-van de Kaa, C.A., Witjes, J.A., Krabbe, P.F.M., Heerschap, A., Barentsz, J.O., 2006, Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology, 241, 449–458.
  • Girouin, N., Mge-Lechevallier, F., Senes, A.T., Bissery, A., Rabilloud, M., Marchal, J.-M., Colombel, M., Lyonnet, D., Rouvire, O., 2007, Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? European Radiology, 17, 1498–1509.
  • Jager, G.J., Ruijter, E.T., van de Kaa, C.A., de la Rosette, J.J., Oosterhof, G.O., Thornbury, J.R., Ruijs, S.H., Barentsz, J.O., 1997, Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology, 203, 645–652.
  • Ogura, K., Maekawa, S., Okubo, K., Aoki, Y., Okada, T., Oda, K., Watanabe, Y., Tsukayama, C., Arai, Y., 2001, Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology, 57, 721–726.
  • Hara, N., Okuizumi, M., Koike, H., Kawaguchi, M., Bilim, V., 2005, Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate, 62, 140–147.
  • Vos, P.C., Hambrock, T., Hulsbergen-van de Kaa, C.A., Fütterer, J.J., Barentsz, J.O., Huisman, H.J., 2008, Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI. Medical Physics, 35, 888–899.
  • Rouvire, O., Hartman, R.P., Lyonnet, D., 2006, Prostate MR imaging at high-field strength: evolution or revolution? European Radiology, 16, 276–284.
  • Sato, C., Naganawa, S., Nakamura, T., Kumada, H., Miura, S., Takizawa, O., Ishigaki, T., 2005, Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. Journal of Magnetic Resonance Imaging, 21, 258–262.
  • Haider, M.A., van der Kwast, T.H., Tanguay, J., Evans, A.J., Hashmi, A.-T., Lockwood, G., Trachtenberg, J., 2007, Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. American Journal of Roentgenology, 189, 323–328.
  • Kim, C.K., Park, B.K., Lee, H.M., Kwon, G.Y., 2007, Value of diffusion weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Investigative Radiology, 42, 842–847.
  • Miao, H., Fukatsu, H., Ishigaki, T., 2007, Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. European Journal of Radiology, 61, 297–302.
  • Morgan, V.A., Kyriazi, S., Ashley, S.E., deSouza, N.M., 2007, Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiology, 48, 695–703.
  • Shimofusa, R., Fujimoto, H., Akamata, H., Motoori, K., Yamamoto, S., Ueda, T., Ito, H., 2005, Diffusion-weighted imaging of prostate cancer. Journal of Computer Assisted Tomography, 29, 149–153.
  • Tanimoto, A., Nakashima, J., Kohno, H., Shinmoto, H., Kuribayashi, S., 2007, Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. Journal of Magnetic Resonance Imaging, 25, 146–152.
  • Yoshimitsu, K., Kiyoshima, K., Irie, H., Tajima, T., Asayama, Y., Hirakawa, M., Ishigami, K., Naito, S., Honda, H., 2008, Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. Journal of Magnetic Resonance Imaging, 27, 132–139.
  • Mazaheri, Y., Shukla-Dave, A., Hricak, H., Fine, S.W., Zhang, J., Inurrigarro, G., Moskowitz, C.S., Ishill, N.M., Reuter, V.E., Touijer, K., Zakian, K.L., Koutcher, J.A., 2008, Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging–correlation with pathologic findings. Radiology, 246, 480–488.
  • deSouza, N.M., Riches, S.F., Vanas, N.J., Morgan, V.A., Ashley, S.A., Fisher, C., Payne, G.S., Parker, C., 2008, Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clinical Radiology, 63, 774–782.
  • Tamada, T., Sone, T., Jo, Y., Toshimitsu, S., Yamashita, T., Yamamoto, A., Tanimoto, D., Ito, K., 2008, Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. Journal of Magnetic Resonance Imaging, 28, 720–726.
  • Choi, Y.J., Kim, J.K., Kim, N., Kim, K.W., Choi, E.K., Cho, K.-S., 2007, Functional MR imaging of prostate cancer. Radiographics, 27, 63–75; discussion 75–77.
  • Issa, B., 2002, In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. Journal of Magnetic Resonance Imaging, 16, 196–200.
  • Pickles, M.D., Gibbs, P., Sreenivas, M., Turnbull, L.W., 2006, Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. Journal of Magnetic Resonance Imaging, 23, 130–134.
  • Macura, K.J., 2008, Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging. Seminars in Roentgenology, 43, 303–313.
  • Smith, E., Dent, G., 2005, Modern Raman Spectroscopy: A Practical Approach (Chichester: John Wiley & Sons).
  • Krafft, C., Sergo, V., 2006, Biomedical applications of Raman and infrared spectroscopy to diagnose tissues. Spectroscopy, 20, 195–218.
  • Bhargava, R., Fernandez, D.C., Hewitt, S.M., Levin, I.W., 2006, High throughput assessment of cells and tissues: Bayesian classification of spectral metrics from infrared vibrational spectroscopic imaging data. Biochimica Biophysica Acta, 1758, 830–845.
  • Fernandez, D.C., Bhargava, R., Hewitt, S.M., Levin, I.W., 2005, Infrared spectroscopic imaging for histopathologic recognition. Nature Biotechnology, 23, 469–474.
  • German, M.J., Hammiche, A., Ragavan, N., Tobin, M.J., Cooper, L.J., Matanhelia, S.S., Hindley, A.C., Nicholson, C.M., Fullwood, N.J., Pollock, H.M., Martin, F.L., 2006, Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell. Biophysics Journal, 90, 3783–3795.
  • Harvey, T.J., Henderson, A., Gazi, E., Clarke, N.W., Brown, M., Faria, E.C., Snook, R.D., Gardner, P., 2007, Discrimination of prostate cancer cells by reflection mode FTIR photoacoustic spectroscopy. Analyst, 132, 292–295.
  • Malins, D.C., Polissar, N.L., Gunselman, S.J., 1997, Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proceedings of the National Academy of Sciences USA, 94, 259–264.
  • Paluszkiewicz, C., Kwiatek, W.M., Banas, A., Kisiel, A., Marcelli, A., Piccinini, A., 2007, SRFTIR spectroscopic preliminary findings of non-cancerous, cancerous, and hyperplastic human prostate tissues. Vibrational Spectroscopy, 43, 237–242.
  • Gazi, E., Baker, M., Dwyer, J., Lockyer, N.P., Gardner, P., Shanks, J.H., Reeve, R.S., Hart, C.A., Clarke, N.W., Brown, M.D., 2006, A correlation of FTIR spectra derived from prostate cancer biopsies with Gleason grade and tumour stage. European Urology, 50, 750–761.
  • Malins, D.C., Johnson, P.M., Barker, E.A., Polissar, N.L., Wheeler, T.M., Anderson, K.M., 2003, Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors. Proceedings of the National Academy of Sciences USA, 100, 5401–5406.
  • Bogomolny, E., Huleihel, M., Suproun, Y., Sahu, R.K., Mordechai, S., 2007, Early spectral changes of cellular malignant transformation using Fourier transform infrared microspectroscopy. Journal of Biomedical Optics, 12, 024003.
  • Crow, P., Ritchie, A., Wright, M., Kendall, C., Stone, N., 2002, Evaluation of Raman spectroscopy to provide a real time optical method for discrimination between normal and abnormal tissue in the prostate. European Urology, Suppl 1, 92–92.
  • Crow, P., Stone, N., Kendall, C.A., Uff, J.S., Farmer, J.A.M., Barr, H., Wright, M.P.J., 2003, The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro. British Journal of Cancer, 89, 106–108.
  • Crow, P., Molckovsky, A., Stone, N., Uff, J., Wilson, B., Wong Kee Song, L.-M., 2005, Assessment of fiberoptic near-infrared Raman spectroscopy for diagnosis of bladder and prostate cancer. Urology, 65, 1126–1130.
  • Crow, P., Barrass, B., Kendall, C., Hart-Prieto, M., Wright, M., Persad, R., Stone, N., 2005, The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines. British Journal of Cancer, 92, 2166–2170.
  • Stone, N., Prieto, M.C.H., Crow, P., Uff, J., Ritchie, A.W., 2007, The use of Raman spectroscopy to provide an estimation of the gross biochemistry associated with urological pathologies. Analytical and Bioanalytical Chemistry, 387, 1657–1668.
  • Taleb, A., Diamond, J., McGarvey, J.J., Beattie, J.R., Toland, C., Hamilton, P.W., 2006, Raman microscopy for the chemometric analysis of tumor cells. The Journal of Physical Chemistry B, 110, 19625–19631.
  • Bertaccini, A., Franceschelli, A., Schiavina, R., Marchiori, D., Baccos, A., Pernetti, R., Granchi, S., Biagi, E., Masotti, L., Martorana, G., 2008, Accuracy of a new echographic method (RULES, radiofrequency ultrasonic local estimators) in prostate cancer diagnosis. Anticancer Research, 28, 1883–1886.
  • Braeckman, J., Autier, P., Garbar, C., Marichal, M.P., Soviany, C., Nir, R., Nir, D., Michielsen, D., Bleiberg, H., Egevad, L., Emberton, M., 2008, Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU International, 101, 293–298.
  • Mohamed, S.S., Salama, M.A., 2008, Prostate cancer spectral multifeature analysis using TRUS images. IEEE Transactions in Medical Imaging, 27, 548–556.
  • Moradi, M., Mousavi, P., Abolmaesumi, P., 2007, Computer-aided diagnosis of prostate cancer with emphasis on ultrasound-based approaches: a review. Ultrasound in Medicine and Biology, 33, 1010–1028.
  • Scheipers, U., König, K., Sommerfeld, H.J., Garcia-Schuermann, M., Senge, T., Ermert, H., 2008, Sonohistology—Ultrasonic tissue characterization for prostate cancer diagnostics. Cancer Biomarkers, 4, 227–250.
  • Heijmink, S.W.T.P.J., van Moerkerk, H., Kiemeney, L.A.L.M., Witjes, J.A., Frauscher, F., Barentsz, J.O., 2006, A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. European Radiology, 16, 927–938.
  • Pallwein, L., Mitterberger, M., Gradl, J., Aigner, F., Horninger, W., Strasser, H., Bartsch, G., zur Nedden, D., Frauscher, F., 2007, Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Current Opinions in Urology, 17, 39–47.
  • van Moerkerk, H., Heijmink, S.W.T.P.J., Hulsbergen-van de Kaa, C., Barentsz, J.O., Witjes, J.A., 2006, Computerized three-dimensional localization of prostate cancer using contrast-enhanced power Doppler and clustering analysis. European Urology, 50, 762–768; discussion 768–769.
  • Albers, M.J., Bok, R., Chen, A.P., Cunningham, C.H., Zierhut, M.L., Zhang, V.Y., Kohler, S.J., Tropp, J., Hurd, R.E., Yen, Y.-F., Nelson, S.-J., Vigneron, D.B., Kurhanewicz, J., 2008, Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Research, 68, 8607–8615.
  • Tessem, M.-B., Swanson, M.G., Keshari, K.R., Albers, M.J., Joun, D., Tabatabai, Z.L., Simko, J.P., Shinohara, K., Nelson, S.J., Vigneron, D.B., Gribbestad, I.S., Kurhanewicz, J., 2008, Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using H-1 HR-MAS spectroscopy of biopsy tissues. Magnetic Resonance in Medicine, 60, 510–516.
  • Aigner, F., Pallwein, L., Pelzer, A., Schaefer, G., Bartsch, G., zur Nedden, D., Frauscher, F., 2007, Value of magnetic resonance imaging in prostate cancer diagnosis. World Journal of Urology, 25, 351–359.
  • Thakral, C., Alhariri, J., Abraham, J.L., 2007, Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications. Contrast Media & Molecular Imaging, 2, 199–205.
  • Chen, M., Dang, H.-D., Wang, J.-Y., Zhou, C., Li, S.-Y., Wang, W.-C., Zhao, W.-F., Yang, Z.-H., Zhong, C.-Y., Li, G.-Z., 2008, Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiology, 49, 602–610.
  • Hambrock, T., Fuetterer, J.J., Huisman, H.J., Hulsbergen-van de Kaa, C., van Basten, J.-P., van Oort, I., Witjes, J.A., Barentsz, J.O., 2008, Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: Technique and feasibility. Investigative Radiology, 43, 686–694.
  • Tamada, T., Sone, T., Jo, Y., Yamamoto, A., Yamashita, T., Egashira, N., Imai, S., Fukunaga, M., 2008, Prostate cancer: relationships between post-biopsy hemorrhage and tumor detectability at MR diagnosis. Radiology, 248, 531–539.
  • Anastasiadis, A.G., Lichy, M.P., Nagele, U., Kuczyk, M.A., Hennenlotter, J., Corvin, S., Sievert, K.-D., Claussen, C.D., Stenzl, A., Schlemmer, H.-P., 2008, MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. European Urology, 50, 738–748; discussion 748–749.
  • Fischer, G.S., Iordachita, I., Csoma, C., Tokuda, J., DiMaio, S.P., Tempany, C.M., Hata, N., Fichtinger, G., 2008, MRI-compatible pneumatic robot for transperineal prostate needle placement. IEEE/ASME Transactions on Mechatronics, 13, 295–305.
  • Lattouf, J.-B., Grubb, R.L., Lee, S.J., Bjurlin, M.A., Albert, P., Singh, A.K., Ocak, I., Choyke, P., Coleman, J.A., 2007, Magnetic resonance imaging directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU International, 99, 1041–1046.
  • Muntener, M., Patriciu, A., Petrisor, D., Schär, M., Ursu, D., Song, D.Y., Stoianovici, D., 2008, Transperineal prostate intervention: robot for fully automated MR imaging—system description and proof of principle in a canine model. Radiology, 247, 543–549.
  • Prieto, M.C.H., Matousek, P., Towrie, M., Parker, A.W., Wright, M., Ritchie, A.W., Stone, N., 2005, Use of picosecond Kerr-gated Raman spectroscopy to suppress signals from both surface and deep layers in bladder and prostate tissue. Journal of Biomedical Optics, 10, 044006-X.
  • Matousek, P., 2006, Inverse spatially offset Raman spectroscopy for deep noninvasive probing of turbid media. Applied Spectroscopy, 60, 1341–1347.
  • Hanlon, E.B., Manoharan, R., Koo, T.-W., Shafer, K.E., Motz, J.T., Fitzmaurice, M., Kramer, J.R., Itzkan, I., Dasari, R.R., Feld, M.S., 2000, Topical Review: Prospects for in vivo Raman spectroscopy. Physics in Medicine and Biology, 45, R1–R59.
  • Komachi, Y., Sato, H., Aizawa, K., Tashiro, H., 2005, Micro-optical fiber probe for use in an intravascular Raman endoscope. Applied Optics, 44, 4722–4732.
  • Bhargava, R., 2007, Towards a practical Fourier transform infrared chemical imaging protocol for cancer histopathology. Analytical and Bioanalytical Chemistry, 389, 1155–1169.
  • Awsare, N.S., Green, J.S.A., Aldwinckle, B., Hanbury, D.C., Boustead, G.B., McNicholas, T.A., 2008, The measurement of psychological distress in men being investigated for the presence of prostate cancer. Prostate Cancer and Prostatic Diseases, 11, 384–389.
  • Phipps, S., 2006, Prostate tissue stiffness as measured with a resonance sensor system: a study on silicone and human prostate tissue in vitro. Medical & Biological Engineering & Computing, 44, 941–943.
  • Dubbelman, Y.D., Wildhagen, M.F., Dohle, G.R., 2008, Penile vascular evaluation and sexual function before and after radical retropubic prostatectomy: 5-year follow-up. International Journal of Andrology, 31, 483–489.
  • Gonzalgo, M.L., Patil, N., Su, L.-M., Patel, V.R., 2008, Minimally invasive surgical approaches and management of prostate cancer. Urologic Clinics of North America, 35, 489–504.
  • Singh, A.K., 2008, Editorial comment on: contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. European Urology, 54, 993.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.